Position in NMRA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,305,449
+$801,184 QoQ
Shares Held
1,356,147
+75.8% QoQ
Ownership
0.722%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#15
of 111 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 50%
Shared 50%
None 0%
Common Shares in NMRA Over Time
Shares Held
Position Value (USD)
Derivatives in NMRA
reported options exposure · as of Jun 30, 2026CallValue
$6,519,840
CallShares
3,835,200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026TUDOR INVESTMENT CORP ET AL holds $411,209,149 across 107 Biotechnology names. NMRA ranks #32 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
943,287 | $66,643,226 | |
| 2 | RPRX |
Royalty Pharma plc
|
610,736 | $34,243,967 | |
| 3 | XENE |
Xenon Pharmaceuticals Inc.
|
545,387 | $32,919,559 | |
| 4 | ABVX |
Abivax S.A.
|
187,335 | $24,964,262 | |
| 5 | INSM |
INSMED Inc
|
195,391 | $20,832,588 | |
| 6 | MLYS |
Mineralys Therapeutics, Inc.
|
738,370 | $19,921,222 | |
| 7 | ABCL |
AbCellera Biologics Inc.
|
2,063,191 | $16,196,049 | |
| 8 | QURE |
uniQure N.V.
|
328,889 | $15,148,627 |
All Filings in NMRA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,305,449 | 1,356,147 | Shares | Defined | 2026-08-14 | |
| 2026-06-30 | $6,519,840 | 3,835,200 | Call | Defined | 2026-08-14 | |
| 2026-03-31 | $1,082,640 | 555,200 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $1,504,265 | 771,418 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||